scispace - formally typeset
G

Geoffrey C. Gurtner

Researcher at Stanford University

Publications -  478
Citations -  32002

Geoffrey C. Gurtner is an academic researcher from Stanford University. The author has contributed to research in topics: Wound healing & Medicine. The author has an hindex of 76, co-authored 423 publications receiving 25985 citations. Previous affiliations of Geoffrey C. Gurtner include Duke University & York University.

Papers
More filters
Journal ArticleDOI

Aging and Diabetes Impair the Neovascular Potential of Adipose-Derived Stromal Cells

TL;DR: It is demonstrated that aging and type 1 and type 2 diabetes impair intrinsic adipose-derived stromal cell function; however, these cells may still be a suitable source of angiogenic cells that can potentially improve neovascularization of ischemic tissues.
Journal ArticleDOI

Paracrine mechanism of angiogenesis in adipose-derived stem cell transplantation.

TL;DR: Transplanted ASCs are preferentially retained in ischemic adipose tissue, although most of the cells eventually undergo cell death after transplantation, suggesting a paracrine mechanism.
Journal ArticleDOI

Capillary Force Seeding of Hydrogels for Adipose-Derived Stem Cell Delivery in Wounds

TL;DR: Capillary seeding of ASCs within a pullulan‐collagen hydrogel bioscaffold provides a convenient and simple way to deliver therapeutic cells to wound environments, and ASC‐seeded constructs display a significant potential to accelerate wound healing that can be easily translated to a clinical setting.
Journal ArticleDOI

Comparative healing of surgical incisions created by the PEAK PlasmaBlade, conventional electrosurgery, and a scalpel.

TL;DR: The PlasmaBlade is a promising new surgical instrument that provides atraumatic, scalpel-like cutting precision and electrosurgical-like hemostasis, resulting in minimal bleeding, tissue injury, and scar formation.
Journal ArticleDOI

Challenges and Opportunities in Drug Delivery for Wound Healing

TL;DR: This review concludes that combinations of delivery mechanisms, such as hydrogels, small molecules, RNA interference, as well as growth factor and stem cell-based therapies (biologics), could offer exciting new opportunities for improving tissue repair.